Researchers pinpoint spike protein regions as targets for passive and active COVID-19 vaccines
Researchers at Stanford University School of Medicine have identified regions of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that have relatively few mutations and might therefore serve as important targets for prophylactic agents against coronavirus disease 2019 (COVID-19).
Drugs that target these “less variable” regions are more likely to be effective against future variants of SARS-CoV-2 because they remain unchanged or “conserved” as the virus mutates and evolves.
Daria Mochly-Rosen and colleagues identified the regions using a database of almost 190,000 individual virus sequences isolated from patients across the globe, thereby reflecting the natural evolution of the virus.
YVONNE MALDONADO, professor of pediatrics and of epidemiology and population health, and
STEVEN ADELSHEIM, professor of psychiatry and behavioral sciences, were awarded supervisor’s medals by Santa Clara County Supervisor Joe Simitian for advancing the well-being of county residents during the COVID-19 pandemic.
Steven Adelsheim and Yvonne Maldonado
They showed admirable resilience and offered others inspiration during a difficult year, Simitian said during an online awards ceremony.
“These folks, by virtue of the way they’ve gone about doing their work, lending their assistance, have inspired all of us to say, ‘We can, and have to, do more,’” Simitian said.
The Disturbing New Symptom of Long COVID Doctors Want You to Know
By Kali Coleman of Best Life |
The Disturbing New Symptom of Long COVID Doctors Want You to Know
There are numerous symptoms that can arise from a COVID infection, and many of these symptoms can linger. Some people suffering from what s come to be known as long COVID find themselves facing enduring symptoms and new complications months after their illness. The more time passes, the more patients report stranger signs of a past coronavirus infection. Most recently, some long COVID patients are reporting a disturbing new symptom:
Amy Siniscalchi, one of the more than 100 patients being treated as part of the COVID-19 Recovery Program at Westchester Medical Center in New York, told ABC 7 that her hands have started to shed after having the coronavirus 10 months earlier.